ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer (AETNBC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02089854
Recruitment Status : Recruiting
First Posted : March 18, 2014
Last Update Posted : December 2, 2016
Sponsor:
Information provided by (Responsible Party):
Peking Union Medical College Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2019
  Study Completion Date : No date given